… al bleeding or perforation, related to previous NSAID therapy.
- History of hemophilia, hypothrombinemia or other clotting disorders
- Renal failure (GFR < 15mL/min/1.73m2).
- Hepatic failure.
- Third trimester of pregnancy
children under 16 years and when breast feeding because of possible risk of Reyes Syndrome.
Identical in all 3 labels. Surrounding text shown from Haleon UK Trading Limited.
… cular haemorrhages; - Haemorrhagic diathesis; coagulation disorders such as haemophilia and thrombocytopenia; - Severe hepatic impairment; - Severe renal impairment; - Severe cardiac insufficiency; - Doses >100 mg/day during the third trimester of pregnancy (see section 4.6); - Methotrexate used at doses >15 mg/week (see section 4.5).
Identical in both labels. Surrounding text shown from G.L Pharma UK Limited.
… ted in section 6.1.
Hypoprothrombinaemia, haemophilia, haemorrhagic disease or a history of bleeding disorders, cerebral haemorrhage and active peptic ulceration or a history of peptic ulceration.
Third trimester of pregnancy (see section 4.6).
In women who are breastfeeding (see section 4.6).
…
Severe hepatic impairment.
Severe renal impairment.
Severe heart failure.
Children aged under 16 years due to a possible risk of Reye's syndrome, unless specifically indicated (see section 4.4).
During last trimester of pregnancy (see section 4.6).
Breast-feeding (see section 4.6).